Hematopoietic stem-cell transplantation for advanced systemic mastocytosis Academic Article uri icon

Overview

MeSH Major

  • Hematopoietic Stem Cell Transplantation
  • Mastocytosis, Systemic

abstract

  • AlloHCT was associated with long-term survival in patients with advanced SM. Although alloHCT may be considered as a viable and potentially curative therapeutic option for advanced SM in the meantime, given that this is a retrospective analysis with no control group, the definitive role of alloHCT will need to be determined by a prospective trial.

authors

publication date

  • October 10, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4876356

Digital Object Identifier (DOI)

  • 10.1200/JCO.2014.55.2018

PubMed ID

  • 25154823

Additional Document Info

start page

  • 3264

end page

  • 74

volume

  • 32

number

  • 29